Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the randomized evaluation of polytetrafluoroethylene COVERed stent in saphenous vein grafts (RECOVERS) trial

Stanković, Goran; Colombo, Carlos Eduardo Dias; Presbitero, P

doi:10.1016/j.accreview.2003.09.003

Cited by 48 publications

(67 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Although the 6-month non Q-wave myocardial infarction rate was higher in the stent-graft group (12.8% versus 4.1%, p =0.013), the cumulative major adverse cardiac event rate was not different (23.1% versus 15.9%, p=0.153). This study also failed to demonstrate a beneficial effect of the JOSTENT stent-graft for saphenous vein graft treatment (Stankovic et al, 2003).…”

Section: Covered Stents For the Treatment Of Saphenous Vein Graftsmentioning

confidence: 63%

“…However, even with the use of stents treatment of saphenous vein graft lesions is associated with a high incidence of acute complications, principally distal embolisation and periprocedural myocardial infarction, because of the more friable atherosclerotic or thrombotic components of the saphenous vein graft lesions (Stankovic et al, 2003). Besides, the results of bare metal stents in saphenous vein grafts are less favourable than those in native vessels, with restenosis rates exceeding 30% (Savage et al, 1997;Silber et al, 2005).…”

Section: Discussionmentioning

confidence: 97%

See 1 more Smart Citation

Percutaneous Intervention Post Coronary Artery Graft Surgery in Patients with Saphenous Vein Graft Disease – State of the Art

Oqueli¹

2012

Coronary Interventions

View full text Add to dashboard Cite

Section: Covered Stents For the Treatment Of Saphenous Vein Graftsmentioning

confidence: 63%

Section: Discussionmentioning

confidence: 97%

Percutaneous Intervention Post Coronary Artery Graft Surgery in Patients with Saphenous Vein Graft Disease – State of the Art

Oqueli¹

2012

Coronary Interventions

View full text Add to dashboard Cite

“…Entretanto, versões prévias estiveram relacionadas a maiores taxas de trombose e outras complicações. Stankovic et al 9 , ao testarem o stent Jomed ® , coberto por membrana de politetrafluoroetileno (PTFE), em PS, observaram maior incidência de IAM aos trinta dias e seis meses quando comparado ao stent não-farmacológico de aço inoxidável. Efeito de borda (reestenose) pelas altas pressões de liberação exigidas para boa expansão do material do stent e até lesões da membrana de PTFE no momento do implante podem explicar tais resultados.…”

Section: Discussionunclassified

Segurança e eficácia de um novo sistema de stent com rede de proteção para prevenção de embolização distal: resultados preliminares do estudo INSPIRE

Maia¹,

Costa²,

Costa³

et al. 2008

Rev. Bras. Cardiol. Invasiva

View full text Add to dashboard Cite

SUMMARY Safety and Efficacy of a Novel Stent System with a Protection Net to Prevent Distal Embolization: Preliminary Results of the INSPIRE TrialBackground: Disturbances in coronary flow due to embolization of thrombus/atheroma fragments are associated with poor prognosis after percutaneous coronary intervention (PCI). Lesions in saphenous vein grafts (SVG) and acute coronary syndromes (ACS) are typically associated with these complications. Although embolic protection devices have shown to reduce the incidence of such complications, they add time and costs to the procedure, and their use is limited to SVG. The newly developed MGuard™ stent combines a microscopic net connected to the struts of a bare metal stent, characterizing this new low-profile device. Objective: To evaluate safety and efficacy of the novel MGuard™ stent system through clinical and angiographic outcomes. Methods: Single-center study including 19 patients with de novo lesions in SVG or with unstable lesions in native vessels as evidenced by angiography. Primary end point included 30-day incidence of major adverse cardiac events (MACE). Results: ACS was the clinical presentation in 60% of cases, and in 55% of the patients the lesion was in a SVG. The MGuard™ stent was successfully delivered in all cases, reaching TIMI 3/blush 3 flow at the end of all procedures. There were no cases of angiographic complications, CK-MB elevations > 3x the reference values after PCI, or MACE at 30 day-follow-up. Conclusion: In this preliminary evaluation, the MGuard™ stent showed high efficacy in a group of patients with highly complex angiographic profile (without the use of adjunctive embolic protection devices). Six-month angiographic follow-up and a larger cohort of patients are necessary to corroborate these results.

show abstract

“…Further evaluation is needed in this regard. 4 Presently he is on regular follow-up and symptom free at 12-month follow-up. In our case, repeat angiogram at 1-month follow-up showed no evidence of restenosis.…”

Section: Discussionmentioning

confidence: 99%

Closure of coronary arterial fistula by covered stent graft during multivessel percutaneous coronary intervention: a case report

Mathew

2018

Int Surg J

View full text Add to dashboard Cite

Coronary arterial fistulae are usually incidental during coronary angiography. We report a case of triple vessel disease treated by multivessel percutaneous coronary intervention using drug-eluting stents (DES) and associated coronary arterial fistula to pulmonary artery with covered stent graft. In this case the coronary fistula from right coronary artery (RCA) was opened during dilatation of the obstructive coronary lesion. RCA had significant coronary lesions in the proximal and distal coronary, mid left anterior descending coronary artery and left circumflex artery, which are revascularized with DES. This patient had coronary arterial fistula arising from right coronary and left main coronary artery. Here, the patient was symptomatic because of the obstructive coronary artery disease.

show abstract

Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the randomized evaluation of polytetrafluoroethylene COVERed stent in saphenous vein grafts (RECOVERS) trial

Cited by 48 publications

References 5 publications

Percutaneous Intervention Post Coronary Artery Graft Surgery in Patients with Saphenous Vein Graft Disease – State of the Art

Percutaneous Intervention Post Coronary Artery Graft Surgery in Patients with Saphenous Vein Graft Disease – State of the Art

Segurança e eficácia de um novo sistema de stent com rede de proteção para prevenção de embolização distal: resultados preliminares do estudo INSPIRE

Closure of coronary arterial fistula by covered stent graft during multivessel percutaneous coronary intervention: a case report

Contact Info

Product

Resources

About